Document Detail

Oxytocin challenge test and intrauterine growth retardation.
MedLine Citation:
PMID:  7246629     Owner:  NLM     Status:  MEDLINE    
On the basis of analyses of the nonstressed fetal heart rate test (NST) and the oxytocin challenge test (OCT) in 85 fetuses with intrauterine growth retardation (IUGR), the predictive power of NST/OCT on fetal outcome and the mechanism of a positive OCT in IUGR were investigated. These fetuses with IUGR exhibited high incidences of nonreactive NSTs (35.3%) and positive OCTs (40%) attributable to a combination of compromised placental function and diminished fetal reserve. Adverse fetal prognosis is most accurately predicted by the joint occurrence of a nonreactive NST and a positive OCT (92%). In such cases, when IUGR is strongly suspected, liberal use of cesarean section is recommended to assure good fetal outcome.
C C Lin; L D Devoe; P River; A H Moawad
Related Documents :
17765669 - Prediction and perinatal outcomes of fetal growth restriction.
3899769 - The influence of antibiotics on the growth of candida albicans in the vagina: an experi...
9343899 - Risk factors for aboriginal low birthweight, intrauterine growth retardation and preter...
3515259 - Value of fetal ponderal index in predicting growth retardation.
6429589 - Fetal growth sustained by parenteral nutrition in pregnancy.
10892419 - Observations on obstetric practice in a multicultural setting.
18491259 - Atrioventricular septal defect in the fetus--associated conditions and outcome in 246 c...
1434509 - Prenatal diagnosis of non-ketotic hyperglycinaemia.
24274419 - Forty years of embryo transfer in cattle: a review focusing on the journal theriogenolo...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  140     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1981 Jun 
Date Detail:
Created Date:  1981-08-10     Completed Date:  1981-08-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  282-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cesarean Section
Estriol / analysis
Fetal Growth Retardation / diagnosis*,  therapy
Fetal Heart / drug effects
Infant Mortality
Oxytocin / diagnostic use*,  pharmacology
Pregnancy Complications / physiopathology
Reg. No./Substance:
50-27-1/Estriol; 50-56-6/Oxytocin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Amniotic fluid phosphatidylglycerol: a potentially useful predictor of intrauterine growth retardati...
Next Document:  Fetal biophysical profile scoring: a prospective study in 1,184 high-risk patients.